Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucokinase (hexokinase 4) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hexokinase family protein | glucokinase (hexokinase 4) | 465 aa | 470 aa | 30.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | hexokinase, putative | 0.0096 | 0.9065 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0096 | 0.9065 | 0.9065 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0101 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0096 | 0.9065 | 0.9065 |
Onchocerca volvulus | 0.009 | 0.8009 | 0.8009 | |
Onchocerca volvulus | 0.0096 | 0.9065 | 0.9065 | |
Brugia malayi | Hexokinase family protein | 0.0096 | 0.9065 | 0.9065 |
Leishmania major | hypothetical protein, conserved | 0.0101 | 1 | 1 |
Onchocerca volvulus | 0.0078 | 0.5906 | 0.5906 | |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1611 | 0.1611 |
Trypanosoma brucei | hexokinase | 0.0096 | 0.9065 | 0.5 |
Onchocerca volvulus | 0.006 | 0.2686 | 0.2686 | |
Brugia malayi | Hexokinase family protein | 0.006 | 0.2686 | 0.2686 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0101 | 1 | 1 |
Brugia malayi | Muscle positioning protein 4 | 0.009 | 0.8009 | 0.8009 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.5906 | 0.5906 |
Onchocerca volvulus | 0.0096 | 0.9065 | 0.9065 | |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3622 | 0.3622 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.8009 | 0.8009 |
Onchocerca volvulus | 0.0078 | 0.5906 | 0.5906 | |
Onchocerca volvulus | 0.0101 | 1 | 1 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0101 | 1 | 1 |
Toxoplasma gondii | kringle domain-containing protein | 0.0101 | 1 | 1 |
Onchocerca volvulus | 0.0078 | 0.5906 | 0.5906 | |
Onchocerca volvulus | 0.0096 | 0.9065 | 0.9065 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0101 | 1 | 1 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0078 | 0.5906 | 0.5906 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 1 | 1 |
Trypanosoma brucei | hexokinase | 0.0096 | 0.9065 | 0.5 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0101 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 1 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.0096 | 0.9065 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.006 | 0.2686 | 0.2686 |
Brugia malayi | Kringle domain containing protein | 0.0101 | 1 | 1 |
Brugia malayi | hexokinase | 0.0096 | 0.9065 | 0.9065 |
Brugia malayi | SEA domain containing protein | 0.0078 | 0.5906 | 0.5906 |
Schistosoma mansoni | hypothetical protein | 0.0078 | 0.5906 | 0.5311 |
Schistosoma mansoni | hexokinase | 0.0096 | 0.9065 | 0.8929 |
Onchocerca volvulus | Hexokinase homolog | 0.006 | 0.2686 | 0.2686 |
Entamoeba histolytica | hexokinase 1 | 0.0096 | 0.9065 | 0.5 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0101 | 1 | 1 |
Onchocerca volvulus | 0.0078 | 0.5906 | 0.5906 | |
Loa Loa (eye worm) | hexokinase type II | 0.0096 | 0.9065 | 0.9065 |
Entamoeba histolytica | hexokinase 2 | 0.0096 | 0.9065 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 2.2 % | Antidiabetic activity in glucose-treated C57BL/J6 db/db mouse assessed as reduction of glucose AUC at 50 mg/kg, po preincubated for 30 mins followed by glucose challenge measured after 30 to 180 mins by oral glucose tolerance test relative to control | ChEMBL. | 24588963 |
EC50 (binding) | = 0.463 uM | Activation of recombinant human pancreatic glucokinase using 10 mM glucose by spectrophotometry | ChEMBL. | 24588963 |
S50 (binding) | = 3.98 mM | Activity of recombinant human pancreatic glucokinase assessed as glucose half-maximal saturation concentration | ChEMBL. | 24588963 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.